Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies for prevention and treatment of herpes simplex viral infections

Monoclonal antibodies for prevention and treatment of herpes simplex viral infections

US Patent 12459987 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HSV-2-delta-gD vaccines and methods for their production and use2024
HSV-2-delta-gD vaccines and methods for their production and use2024
Double auxotrophic mycobacterium and uses thereof2024
Attb cell line, transgenic cell lines derived therefrom, and methods of making t2024
Methods of using HSV-2 single cycle virus delta-gD and HSV-2 recombinant glycopr2023
Double auxotrophic Mycobacterium and uses thereof2023
Prevention and treatment of viral infections2022
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021
Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) va2021
Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) va2021
Methods to identify prime and boost immunogens for use in a B cell lineage-based2020